|
CA2800158A1
|
|
Vaccines comprising cholesterol and cpg as sole adjuvant-carrier molecules
|
|
AU2010243285A1
|
|
Pneumococcal vaccine and uses thereof
|
|
AU2009325926A1
|
|
Immunostimulatory oligonucleotides
|
|
WO2009030996A1
|
|
Triazole compounds as toll-like receptor (tlr) agonists
|
|
WO2009030998A1
|
|
Pyrimidine compounds as toll-like receptor (tlr) agonists
|
|
WO2008152471A1
|
|
Quinazoline derivative useful as toll-like receptor antagonist
|
|
KR20100010509A
|
|
Class a oligonucleotides with immunostimulatory potency
|
|
WO2008057529A2
|
|
Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp)
|
|
WO2008045543A1
|
|
Substituted 4h-imidazo [4, 5, 1-ij] [1, 6] naphthyridine-9-amines and their pharmaceutical use
|
|
BRPI0719445A2
|
|
COMPOSITIONS OF TLR AND ANTIVIAL LIGANDS.
|
|
WO2008036312A1
|
|
Fungicidal methods using immune response modifier compounds
|
|
WO2008033432A2
|
|
Immune modulation by chemically modified ribonucleosides and oligoribonucleotides
|
|
AU2007293363A1
|
|
Small molecule inhibitors of toll-like receptor 9
|
|
WO2007143526A2
|
|
Substituted tetrahydroimidazonaphthyridines and methods
|
|
WO2007106854A2
|
|
Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods
|
|
WO2007079171A2
|
|
Treatment for hodgkin's lymphoma
|
|
CA2634017A1
|
|
Substituted imidazoquinolines, imidazonaphthyridines, and imidazopyridines, compositions, and methods
|
|
KR20080083270A
|
|
Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
|
|
EA014244B1
|
|
METHOD FOR1H-IMIDAZO[4,5-c]PYRIDINES AND ANALOGS THEREOF
|
|
CN101312975A
|
|
Method for 1h-imidazo[4,5-c]pyridines and analogs thereof
|
